Michael Heathman, M.S.

Group Leader, Senior Principal Scientist I

Michael brings over 30 years of experience in the pharmaceutical industry.  Prior to joining Metrum Research Group in 2018, he was Head of Global Pharmacometrics at Eli Lilly and Company, where he led efforts to apply PK/PD modeling and simulation to all phases of drug development.  He has extensive experience in the application of pharmacometrics to support quantitative decision making across a broad range of disease states and therapeutic areas.

Recent publications by this scientist

Pharmacokinetics of vaginal versus buccal misoprostol for labor induction at term

May 22, 2022

Yana VorontsovaDavid M. HaasKathleen FlanneryAndrea R. MastersLarissa L. SilvaRebecca C. PiersonBrittany YeleyGraham HoggDavid GuiseMichael HeathmanSara K. Quinney. Clin Transl Sci2022001– 9. doi:10.1111/cts.13306

View More

Pharmacokinetic modeling of R and S-Methadone and their metabolites to study the effects of various covariates in post-operative children

August 26, 2021

Aruldhas BW, Quinney SK, Overholser BR, Heathman MA, Masters AR, Ly RC, Gao H, Packiasabapathy S, Sadhasivam S. CPT Pharmacometrics Syst Pharmacol2021001– 12. doi:10.1002/psp4.12687

View More

Postprandial triglyceride reduction following acute treatment of a selective 5-hydroxytryptamine-2c agonist and characterization using a semi-physiological model.

April 23, 2021

Leohr J, Heathman M, Kjellsson MC. Diabetes Obes Metab. 2021 Apr;23(4):1001-1010. doi: 10.1111/dom.14306.

View More